DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Loibl S, Untch M, Burchardi N. et al.
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.
Ann Oncol 2019;
30: 1279-1288
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.